MiMedx off premarket on receipt of civil subpoena

• MiMedx (NASDAQ:MDXG) is off 11% premarket on light volume in response to its announcement that it has received a subpoena from the Office of Inspector General of the Department of Health and Human Services in connection with a civil investigation into matters related to the company's sales and marketing activities.
• The company plans to cooperate fully with investigators.